Opthea Limited (OPT)
USD 3.41
(1.49%)
USD 3.41
(1.49%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -220.24 Million USD | -3.95% |
| 2023 | -142.52 Million USD | -53.55% |
| 2022 | -92.81 Million USD | -104.69% |
| 2021 | -45.34 Million USD | -309.22% |
| 2020 | -11.08 Million USD | 25.9% |
| 2019 | -14.95 Million USD | -14.18% |
| 2018 | -13.09 Million USD | -180.42% |
| 2017 | -4.67 Million USD | 1.37% |
| 2016 | -4.73 Million USD | -15.83% |
| 2015 | -4.08 Million USD | -8.48% |
| 2014 | -3.76 Million USD | 6.04% |
| 2013 | -4.01 Million USD | 19.92% |
| 2012 | -5 Million USD | 57.32% |
| 2011 | -11.73 Million USD | -135.78% |
| 2010 | -4.97 Million USD | 22.22% |
| 2009 | -6.39 Million USD | -506.86% |
| 2008 | -1.05 Million USD | -111.1% |
| 2007 | 9.5 Million USD | 368.06% |
| 2006 | -3.54 Million USD | -128.2% |
| 2005 | 12.57 Million USD | 340.33% |
| 2004 | 2.85 Million USD | 277.95% |
| 2003 | -1.6 Million USD | 12.12% |
| 2002 | -1.82 Million USD | -343.27% |
| 2001 | -411.83 Thousand USD | -193.94% |
| 2000 | 438.38 Thousand USD | -99.96% |
| 1999 | 1.05 Billion USD | 138721.1% |
| 1998 | -759.04 Thousand USD | 3.92% |
| 1997 | -790.05 Thousand USD | -16.74% |
| 1996 | -676.74 Thousand USD | -101.04% |
| 1995 | -336.61 Thousand USD | -920.53% |
| 1994 | -32.98 Thousand USD | 85.59% |
| 1993 | -228.91 Thousand USD | -407.75% |
| 1992 | -45.08 Thousand USD | 57.64% |
| 1991 | -106.43 Thousand USD | 72.62% |
| 1990 | -388.8 Thousand USD | -24.6% |
| 1989 | -312.04 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -96.93 Million USD | 0.0% |
| 2024 FY | -221.04 Million USD | -55.1% |
| 2024 Q4 | -124.05 Million USD | 0.0% |
| 2023 FY | -142.52 Million USD | -53.55% |
| 2023 Q4 | -64.92 Million USD | 0.0% |
| 2023 Q2 | -76.99 Million USD | 0.0% |
| 2022 FY | -92.81 Million USD | -104.69% |
| 2022 Q4 | -55.1 Million USD | 0.0% |
| 2022 Q2 | -37.59 Million USD | 0.0% |
| 2021 FY | -45.34 Million USD | -309.22% |
| 2021 Q2 | -25.28 Million USD | 0.0% |
| 2021 Q4 | -19.61 Million USD | 0.0% |
| 2020 FY | -11.08 Million USD | 25.9% |
| 2020 Q4 | -5.84 Million USD | 0.0% |
| 2020 Q2 | -5.21 Million USD | 0.0% |
| 2019 FY | -14.95 Million USD | -14.18% |
| 2019 Q2 | -8.17 Million USD | 0.0% |
| 2019 Q4 | -6.79 Million USD | 0.0% |
| 2018 Q4 | -4.21 Million AUD | 0.0% |
| 2018 Q2 | -8.92 Million USD | 0.0% |
| 2018 FY | -13.09 Million USD | -180.42% |
| 2017 FY | -4.67 Million USD | 1.37% |
| 2017 Q4 | -2.99 Million AUD | 0.0% |
| 2017 Q2 | -1.65 Million USD | 0.0% |
| 2016 Q2 | -1.24 Million USD | 0.0% |
| 2016 FY | -4.73 Million USD | -15.83% |
| 2016 Q4 | -3.57 Million AUD | 0.0% |
| 2015 FY | -4.08 Million USD | -8.48% |
| 2015 Q4 | -1.82 Million AUD | 0.0% |
| 2015 Q2 | -2.4 Million USD | 0.0% |
| 2014 Q2 | -1.41 Million USD | 0.0% |
| 2014 Q4 | -2.28 Million AUD | 0.0% |
| 2014 FY | -3.76 Million USD | 6.04% |
| 2013 Q3 | -1.24 Million USD | 67.4% |
| 2013 FY | -4.01 Million USD | 19.92% |
| 2013 Q2 | -3.8 Million USD | -202.54% |
| 2013 Q1 | -1.25 Million USD | 0.0% |
| 2013 Q4 | -870.6 Thousand USD | 29.8% |
| 2012 FY | -5 Million USD | 57.32% |
| 2012 Q4 | - USD | 100.0% |
| 2012 Q3 | -1.25 Million USD | 1.92% |
| 2012 Q2 | -1.28 Million USD | 48.73% |
| 2012 Q1 | -2.49 Million USD | 0.0% |
| 2011 Q1 | -1.68 Million USD | 0.0% |
| 2011 Q3 | -2.65 Million USD | -3.95% |
| 2011 Q4 | - USD | 100.0% |
| 2011 FY | -11.73 Million USD | -135.78% |
| 2011 Q2 | -2.55 Million USD | -51.75% |
| 2010 Q3 | -1.59 Million USD | -3.18% |
| 2010 Q1 | -2.16 Million USD | 0.0% |
| 2010 FY | -4.97 Million USD | 22.22% |
| 2010 Q4 | - USD | 100.0% |
| 2010 Q2 | -1.54 Million USD | 28.36% |
| 2009 Q1 | -221.18 Thousand USD | 0.0% |
| 2009 Q3 | -1.72 Million USD | -7.22% |
| 2009 FY | -6.39 Million USD | -506.86% |
| 2009 Q4 | - USD | 100.0% |
| 2009 Q2 | -1.6 Million USD | -625.57% |
| 2008 Q3 | -263.22 Thousand USD | -2.02% |
| 2008 Q1 | 2.47 Million USD | 0.0% |
| 2008 Q2 | -258 Thousand USD | -110.43% |
| 2008 Q4 | - USD | 100.0% |
| 2008 FY | -1.05 Million USD | -111.1% |
| 2007 Q1 | -1.21 Million USD | 0.0% |
| 2007 Q4 | - USD | -100.0% |
| 2007 FY | 9.5 Million USD | 368.06% |
| 2007 Q2 | 2.16 Million USD | 279.14% |
| 2007 Q3 | 2.26 Million USD | 4.45% |
| 2006 FY | -3.54 Million USD | -128.2% |
| 2006 Q3 | -1.15 Million USD | 5.28% |
| 2006 Q2 | -1.21 Million USD | -116074.66% |
| 2006 Q4 | - USD | 100.0% |
| 2006 Q1 | 1047.82 USD | 0.0% |
| 2005 Q2 | 1066.41 USD | -99.9% |
| 2005 Q3 | 1062.27 USD | -0.39% |
| 2005 Q4 | - USD | -100.0% |
| 2005 FY | 12.57 Million USD | 340.33% |
| 2005 Q1 | 1.04 Million USD | 0.0% |
| 2004 Q3 | 1.1 Million USD | -0.93% |
| 2004 Q1 | -598.53 Thousand USD | 0.0% |
| 2004 Q4 | - USD | -100.0% |
| 2004 Q2 | 1.11 Million USD | 285.78% |
| 2004 FY | 2.85 Million USD | 277.95% |
| 2003 Q1 | -781.12 Thousand USD | 0.0% |
| 2003 Q2 | -515.1 Thousand USD | 34.06% |
| 2003 FY | -1.6 Million USD | 12.12% |
| 2003 Q3 | -526.22 Thousand USD | -2.16% |
| 2003 Q4 | - USD | 100.0% |
| 2002 Q1 | 6520.59 USD | 0.0% |
| 2002 Q2 | -730.15 Thousand USD | -11297.64% |
| 2002 Q4 | - USD | 100.0% |
| 2002 Q3 | -762.66 Thousand USD | -4.45% |
| 2002 FY | -1.82 Million USD | -343.27% |
| 2001 Q2 | 7295.45 USD | -95.64% |
| 2001 FY | -411.83 Thousand USD | -193.94% |
| 2001 Q4 | - USD | -100.0% |
| 2001 Q3 | 6494.88 USD | -10.97% |
| 2001 Q1 | 167.22 Thousand USD | 0.0% |
| 2000 FY | 438.38 Thousand USD | -99.96% |
| 2000 Q1 | 388.57 Thousand USD | 0.0% |
| 2000 Q4 | - USD | -100.0% |
| 2000 Q2 | 198.02 Thousand USD | -49.04% |
| 2000 Q3 | 186.91 Thousand USD | -5.61% |
| 1999 Q3 | 374.52 Thousand USD | 0.27% |
| 1999 Q1 | - USD | 0.0% |
| 1999 FY | 1.05 Billion USD | 138721.1% |
| 1999 Q2 | 373.52 Thousand USD | 0.0% |
| 1999 Q4 | - USD | -100.0% |
| 1998 Q4 | - USD | 0.0% |
| 1998 Q2 | - USD | -100.0% |
| 1998 Q3 | - USD | 0.0% |
| 1998 Q1 | 1062.36 USD | 0.0% |
| 1998 FY | -759.04 Thousand USD | 3.92% |
| 1997 FY | -790.05 Thousand USD | -16.74% |
| 1997 Q2 | 1121.59 USD | -85.81% |
| 1997 Q1 | 7906.80 USD | 0.2% |
| 1997 Q3 | 1147.51 USD | 2.31% |
| 1997 Q4 | - USD | -100.0% |
| 1996 Q4 | 7891.20 USD | 1.03% |
| 1996 Q1 | - USD | 0.0% |
| 1996 FY | -676.74 Thousand USD | -101.04% |
| 1996 Q2 | 7505.60 USD | 0.0% |
| 1996 Q3 | 7810.60 USD | 4.06% |
| 1995 Q3 | - USD | 0.0% |
| 1995 Q2 | - USD | 0.0% |
| 1995 Q1 | - USD | 0.0% |
| 1995 FY | -336.61 Thousand USD | -920.53% |
| 1995 Q4 | - USD | 0.0% |
| 1994 Q4 | - USD | 0.0% |
| 1994 Q3 | - USD | 0.0% |
| 1994 Q2 | - USD | 0.0% |
| 1994 Q1 | - USD | 0.0% |
| 1994 FY | -32.98 Thousand USD | 85.59% |
| 1993 Q4 | - USD | 0.0% |
| 1993 FY | -228.91 Thousand USD | -407.75% |
| 1993 Q2 | - USD | 0.0% |
| 1993 Q1 | - USD | 0.0% |
| 1993 Q3 | - USD | 0.0% |
| 1992 FY | -45.08 Thousand USD | 57.64% |
| 1992 Q1 | - USD | 0.0% |
| 1992 Q4 | - USD | 0.0% |
| 1992 Q3 | - USD | 0.0% |
| 1992 Q2 | - USD | 0.0% |
| 1991 Q1 | - USD | 0.0% |
| 1991 Q3 | - USD | 0.0% |
| 1991 FY | -106.43 Thousand USD | 72.62% |
| 1991 Q4 | - USD | 0.0% |
| 1991 Q2 | - USD | 0.0% |
| 1990 Q3 | - USD | 0.0% |
| 1990 FY | -388.8 Thousand USD | -24.6% |
| 1990 Q1 | - USD | 0.0% |
| 1990 Q2 | - USD | 0.0% |
| 1990 Q4 | - USD | 0.0% |
| 1989 Q3 | - USD | 0.0% |
| 1989 Q4 | - USD | 0.0% |
| 1989 Q2 | - USD | 0.0% |
| 1989 FY | -312.04 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | -23430.139% |
| TRACON Pharmaceuticals, Inc. | -3.58 Million USD | -6038.297% |
| Vaxxinity, Inc. | -56.93 Thousand USD | -386737.575% |
| IO Biotech, Inc. | -86.08 Million USD | -155.849% |
| Aridis Pharmaceuticals, Inc. | -30.74 Million USD | -616.258% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | -717.589% |
| MEI Pharma, Inc. | 17.77 Million USD | 1338.846% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | -28.294% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | -9.251% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | -489.829% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | -5.198% |
| Keros Therapeutics, Inc. | -152.99 Million USD | -43.957% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | -1584.856% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | 2.223% |
| Agenus Inc. | -245.76 Million USD | 10.384% |
| AlloVir, Inc. | -190.41 Million USD | -15.662% |
| CRISPR Therapeutics AG | -153.61 Million USD | -43.377% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | -253.774% |
| NextCure, Inc. | -62.72 Million USD | -251.135% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | -273.401% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | -777.773% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -804.883% |
| Aadi Bioscience, Inc. | -65.76 Million USD | -234.893% |
| Senti Biosciences, Inc. | -92.91 Million USD | -137.026% |
| Akebia Therapeutics, Inc. | -51.92 Million USD | -324.154% |
| Alzamend Neuro, Inc. | -9.94 Million USD | -2113.99% |
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | 49.972% |
| BioLineRx Ltd. | -60.61 Million USD | -263.352% |
| Compass Therapeutics, Inc. | -42.49 Million USD | -418.29% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | -200.274% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | -545.852% |
| Janux Therapeutics, Inc. | -58.29 Million USD | -277.819% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | -228.744% |
| AbCellera Biologics Inc. | -146.39 Million USD | -50.441% |
| ADMA Biologics, Inc. | -28.23 Million USD | -679.922% |
| Aptorum Group Limited | -2.82 Million USD | -7697.155% |
| AnaptysBio, Inc. | -163.61 Million USD | -34.607% |
| Ardelyx, Inc. | -66.06 Million USD | -233.362% |
| Arrowhead Pharmaceuticals, Inc. | -205.27 Million USD | -7.291% |
| Bicycle Therapeutics plc | -180.66 Million USD | -21.907% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | -23.004% |
| C4 Therapeutics, Inc. | -132.49 Million USD | -66.229% |
| Clearside Biomedical, Inc. | -32.48 Million USD | -577.981% |
| Chimerix, Inc. | -82.09 Million USD | -168.277% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | -393.78% |
| Dyadic International, Inc. | -6.79 Million USD | -3141.018% |
| Elevation Oncology, Inc. | -45.7 Million USD | -381.888% |
| ESSA Pharma Inc. | -26.58 Million USD | -728.528% |
| Fortress Biotech, Inc. | -60.63 Million USD | -263.214% |
| Fate Therapeutics, Inc. | -160.92 Million USD | -36.858% |
| GlycoMimetics, Inc. | -36.89 Million USD | -496.871% |
| Fortress Biotech, Inc. | -60.63 Million USD | -263.214% |
| ChromaDex Corporation | -4.93 Million USD | -4360.148% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | -2707.281% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | -124.4% |
| Caribou Biosciences, Inc. | -102.07 Million USD | -115.776% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | -94.972% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | 8.75% |
| Incyte Corporation | 597.59 Million USD | 136.854% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | -63.001% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | -1989.98% |
| Jaguar Health, Inc. | -41.3 Million USD | -433.274% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | 153.092% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -2490.779% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | 522.292% |
| ContextLogic Inc. | -317 Million USD | 30.523% |
| Lantern Pharma Inc. | -15.96 Million USD | -1279.83% |
| Madrigal Pharmaceuticals, Inc. | -373.63 Million USD | 41.053% |
| MiMedx Group, Inc. | 67.43 Million USD | 426.58% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | -55.753% |
| Structure Therapeutics Inc. | -89.62 Million USD | -145.751% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | -169.971% |
| Onconetix, Inc. | -37.4 Million USD | -488.73% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | -457.872% |
| Psyence Biomedical Ltd. | -51.15 Million USD | -330.505% |
| PDS Biotechnology Corporation | -42.94 Million USD | -412.88% |
| Precigen, Inc. | -95.9 Million USD | -129.649% |
| Pharming Group N.V. | -10.54 Million USD | -1987.999% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | -797.372% |
| PureTech Health plc | -65.69 Million USD | -235.239% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | -88.567% |
| Royalty Pharma plc | 1.13 Billion USD | 119.407% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -804.883% |
| Seer, Inc. | -86.27 Million USD | -155.273% |
| Sangamo Therapeutics, Inc. | -257.83 Million USD | 14.579% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | -708.584% |
| Acelyrin, Inc. | -381.64 Million USD | 42.291% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | -1755839.954% |
| Pyxis Oncology, Inc. | -73.79 Million USD | -198.471% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | -1087.539% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | -33.826% |
| TG Therapeutics, Inc. | 12.67 Million USD | 1838.022% |
| Alkermes plc | 355.75 Million USD | 161.908% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | -3194.572% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | -3854.787% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | -348.376% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | -2105.509% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | -650.092% |
| Wave Life Sciences Ltd. | -57.51 Million USD | -282.943% |
| Avidity Biosciences, Inc. | -212.22 Million USD | -3.78% |
| Geron Corporation | -184.12 Million USD | -19.614% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -985.418% |
| Summit Therapeutics Inc. | -614.92 Million USD | 64.184% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | -110.357% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | -526.756% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | -1057.41% |
| Innoviva, Inc. | 179.72 Million USD | 222.546% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | -304.693% |
| Vaxcyte, Inc. | -402.26 Million USD | 45.25% |
| Molecular Templates, Inc. | -8.12 Million USD | -2611.006% |
| VYNE Therapeutics Inc. | -28.45 Million USD | -674.083% |
| Sorrento Therapeutics, Inc. | -572.84 Million USD | 61.553% |
| Viracta Therapeutics, Inc. | -51.05 Million USD | -331.357% |
| Novavax, Inc. | -545.06 Million USD | 59.593% |
| eFFECTOR Therapeutics, Inc. | -35.81 Million USD | -515.012% |
| Scopus BioPharma Inc. | -11.6 Million USD | -1797.032% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | 408.419% |
| Precision BioSciences, Inc. | -61.31 Million USD | -259.174% |
| GT Biopharma, Inc. | -7.59 Million USD | -2799.067% |
| ImmuCell Corporation | -5.77 Million USD | -3713.982% |
| Immix Biopharma, Inc. | -15.42 Million USD | -1327.729% |
| Mesoblast Limited | -87.95 Million USD | -150.4% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | 10.323% |
| Aptose Biosciences Inc. | -51.2 Million USD | -330.102% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | -124.056% |
| Soligenix, Inc. | -6.14 Million USD | -3486.579% |
| Century Therapeutics, Inc. | -136.67 Million USD | -61.145% |
| Kura Oncology, Inc. | -152.63 Million USD | -44.297% |
| TScan Therapeutics, Inc. | -89.21 Million USD | -146.858% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | 39048.504% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | -38606.873% |
| Autolus Therapeutics plc | -208.38 Million USD | -5.691% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | -206.326% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | -211.098% |
| Eterna Therapeutics Inc. | -21.66 Million USD | -916.439% |
| GRI Bio, Inc. | -13.03 Million USD | -1589.362% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | -5226.834% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | -77.494% |
| IGM Biosciences, Inc. | -246.41 Million USD | 10.622% |
| INmune Bio, Inc. | -30 Million USD | -633.945% |
| Heron Therapeutics, Inc. | -110.55 Million USD | -99.208% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -421.978% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -1279.82% |
| Entero Therapeutics, Inc. | -15.79 Million USD | -1294.38% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | -269.007% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | -117.702% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | 20.239% |
| Coherus BioSciences, Inc. | -237.89 Million USD | 7.419% |
| Verastem, Inc. | -87.36 Million USD | -152.088% |
| Abeona Therapeutics Inc. | -54.18 Million USD | -306.441% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | -36.511% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | -88.793% |
| Histogen Inc. | -10.62 Million USD | -1973.648% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | -1441.582% |
| Surrozen, Inc. | -43.04 Million USD | -411.691% |
| Organovo Holdings, Inc. | -14.67 Million USD | -1401.207% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -4229.484% |
| Ovid Therapeutics Inc. | -52.33 Million USD | -320.8% |
| Panbela Therapeutics, Inc. | -25.26 Million USD | -771.797% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | -2535.394% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | -45.774% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | -350.153% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | -640.932% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | -2014.114% |
| Apollomics, Inc. | -172.6 Million USD | -27.602% |
| Amarin Corporation plc | -59.11 Million USD | -272.584% |
| Turnstone Biologics Corp. | -55.2 Million USD | -298.989% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | -49.863% |
| Synaptogenix, Inc. | -6.03 Million USD | -3547.296% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | -1258.848% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | -182.289% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -4496.549% |
| Monopar Therapeutics Inc. | -8.4 Million USD | -2521.245% |
| Exelixis, Inc. | 207.76 Million USD | 206.005% |
| Better Therapeutics, Inc. | -39.76 Million USD | -453.929% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | -53.001% |
| Apellis Pharmaceuticals, Inc. | -528.62 Million USD | 58.337% |
| NLS Pharmaceutics AG | -12.17 Million USD | -1709.412% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | -2725.54% |
| Gritstone bio, Inc. | -138.49 Million USD | -59.031% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -241.646% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -5406.121% |
| Avid Bioservices, Inc. | -140.75 Million USD | -56.474% |
| Insmed Incorporated | -749.56 Million USD | 70.617% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | -1349.962% |
| MediWound Ltd. | -6.71 Million USD | -3179.364% |
| OmniAb, Inc. | -50.61 Million USD | -335.098% |
| Alector, Inc. | -130.39 Million USD | -68.909% |
| Seres Therapeutics, Inc. | -113.72 Million USD | -93.664% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | -324.792% |
| Zai Lab Limited | -334.62 Million USD | 34.181% |
| Revance Therapeutics, Inc. | -323.98 Million USD | 32.021% |
| Aura Biosciences, Inc. | -76.4 Million USD | -188.245% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | 6.133% |
| Immunic, Inc. | -93.61 Million USD | -135.271% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | -62.07% |
| Veracyte, Inc. | -74.4 Million USD | -196.008% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | -2769.398% |
| FibroGen, Inc. | -284.23 Million USD | 22.513% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -739.593% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -3045.467% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | -1069.467% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | -876.467% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | 547.001% |
| Galecto, Inc. | -38.34 Million USD | -474.31% |
| Calithera Biosciences, Inc. | -18.86 Million USD | -1067.402% |
| Fortrea Holdings Inc. | -3.4 Million USD | -6377.709% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | -73.906% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | -1164.96% |
| XBiotech Inc. | -24.55 Million USD | -796.861% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -241.646% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | -251.375% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | -123.764% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | -927.872% |
| Theravance Biopharma, Inc. | -55.19 Million USD | -299.04% |
| Ultragenyx Pharmaceutical Inc. | -606.63 Million USD | 63.695% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | -222.675% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | 2.78% |
| Gain Therapeutics, Inc. | -22.26 Million USD | -889.073% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | -0.242% |
| NexImmune, Inc. | -32.34 Million USD | -580.928% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | -4066.065% |
| Marker Therapeutics, Inc. | -14.04 Million USD | -1468.018% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | 105.571% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | -809.302% |
| Ainos, Inc. | -13.77 Million USD | -1499.371% |
| Pluri Inc. | -20.88 Million USD | -954.395% |
| Prothena Corporation plc | -147.02 Million USD | -49.796% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | -93.414% |
| Celularity Inc. | -196.29 Million USD | -12.2% |
| Rallybio Corporation | -74.56 Million USD | -195.373% |
| Cue Biopharma, Inc. | -50.73 Million USD | -334.12% |
| MeiraGTx Holdings plc | -84.02 Million USD | -162.109% |
| Omeros Corporation | -117.81 Million USD | -86.942% |
| Humacyte, Inc. | -110.77 Million USD | -98.818% |
| Immunocore Holdings plc | -55.28 Million USD | -298.361% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | -1124.656% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | -860.456% |
| Blueprint Medicines Corporation | -506.98 Million USD | 56.558% |
| CalciMedica, Inc. | -34.35 Million USD | -541.04% |
| Cabaletta Bio, Inc. | -67.67 Million USD | -225.441% |
| Scholar Rock Holding Corporation | -165.78 Million USD | -32.845% |
| Sana Biotechnology, Inc. | -283.25 Million USD | 22.246% |
| Pulmatrix, Inc. | -14.12 Million USD | -1459.678% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | -525.777% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | -166.514% |
| Intellia Therapeutics, Inc. | -481.19 Million USD | 54.23% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | -110.012% |
| Cytokinetics, Incorporated | -526.24 Million USD | 58.148% |
| Eloxx Pharmaceuticals, Inc. | -36.06 Million USD | -510.681% |
| Nutriband Inc. | -5.48 Million USD | -3915.123% |
| Protara Therapeutics, Inc. | -40.42 Million USD | -444.884% |
| Vor Biopharma Inc. | -117.86 Million USD | -86.863% |
| Roivant Sciences Ltd. | 4.34 Billion USD | 105.064% |
| Evogene Ltd. | -23.87 Million USD | -822.325% |
| ProKidney Corp. | -35.46 Million USD | -520.96% |
| Applied Therapeutics, Inc. | -119.76 Million USD | -83.898% |
| BridgeBio Pharma, Inc. | -643.2 Million USD | 65.758% |
| CorMedix Inc. | -46.33 Million USD | -375.282% |
| Tango Therapeutics, Inc. | -101.74 Million USD | -116.467% |
| Galectin Therapeutics Inc. | -41.06 Million USD | -436.313% |
| Atai Life Sciences N.V. | -40.22 Million USD | -447.539% |
| Renovaro Biosciences Inc. | -80.65 Million USD | -173.083% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | -191.63% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | 24.624% |
| Sagimet Biosciences Inc. | -27.87 Million USD | -690.078% |
| MediciNova, Inc. | -8.57 Million USD | -2469.465% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | -78.656% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -2529.181% |
| GeoVax Labs, Inc. | -25.96 Million USD | -748.169% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | 7.94% |
| Biomea Fusion, Inc. | -117.25 Million USD | -87.832% |
| PTC Therapeutics, Inc. | -626.6 Million USD | 64.851% |
| Mereo BioPharma Group plc | -29.46 Million USD | -647.445% |
| Cullinan Oncology, Inc. | -153.16 Million USD | -43.797% |
| Absci Corporation | -110.56 Million USD | -99.195% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -630.488% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | -118.414% |
| Dyne Therapeutics, Inc. | -235.93 Million USD | 6.652% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | 1663.775% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | -14.138% |
| Allakos Inc. | -185.7 Million USD | -18.6% |
| Imunon, Inc. | -19.51 Million USD | -1028.58% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | -126.272% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | 307.502% |
| BioAtla, Inc. | -123.46 Million USD | -78.389% |
| NLS Pharmaceutics AG | -12.17 Million USD | -1709.412% |
| Bio-Path Holdings, Inc. | -16.07 Million USD | -1269.835% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | 32.702% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | -496.071% |
| XOMA Corporation | -40.83 Million USD | -439.399% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | -116.199% |
| Cara Therapeutics, Inc. | -118.51 Million USD | -85.838% |
| aTyr Pharma, Inc. | -50.38 Million USD | -337.084% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | -151.191% |
| Akero Therapeutics, Inc. | -151.75 Million USD | -45.126% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | 7.358% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | -527.131% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | -2621.747% |
| Akari Therapeutics, Plc | -10 Million USD | -2100.661% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -327032.722% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | 178.213% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -3204.508% |
| UroGen Pharma Ltd. | -102.24 Million USD | -115.408% |
| Sutro Biopharma, Inc. | -106.79 Million USD | -106.233% |
| ZIVO Bioscience, Inc. | -7.77 Million USD | -2731.9% |
| Orgenesis Inc. | -55.36 Million USD | -297.829% |
| Entera Bio Ltd. | -8.88 Million USD | -2377.693% |
| GH Research PLC | -35.58 Million USD | -518.884% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | -956.824% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | -184.595% |
| Xencor, Inc. | -126.08 Million USD | -74.675% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | -5748.633% |
| Replimune Group, Inc. | -215.79 Million USD | -2.061% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | -935.627% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | 8878.083% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -3204.508% |
| Portage Biotech Inc. | -75.33 Million USD | -192.335% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -2529.181% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | -127.864% |
| OncoCyte Corporation | -27.78 Million USD | -692.78% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | -1541.489% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | -1880.324% |
| Purple Biotech Ltd. | -19.88 Million USD | -1007.858% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | -3037.799% |
| scPharmaceuticals Inc. | -54.81 Million USD | -301.828% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | -1158.085% |
| HilleVax, Inc. | -123.56 Million USD | -78.238% |
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | -2079.105% |
| Tharimmune, Inc. | -9.31 Million USD | -2263.342% |
| Genprex, Inc. | -30.86 Million USD | -613.671% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | 6.647% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | -631.847% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | -12259.265% |
| Virios Therapeutics, Inc. | -5.29 Million USD | -4058.638% |
| OKYO Pharma Limited | -16.82 Thousand USD | -1308881.181% |
| Savara Inc. | -54.69 Million USD | -302.651% |
| Curis, Inc. | -47.41 Million USD | -364.518% |
| Daré Bioscience, Inc. | -30.16 Million USD | -630.212% |
| Carmell Therapeutics Corporation | -15.44 Million USD | -1325.969% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | -638.696% |
| BeiGene, Ltd. | -881.7 Million USD | 75.021% |
| Kiromic BioPharma, Inc. | -21.29 Million USD | -934.292% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | 49.528% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | -178.946% |
| Erasca, Inc. | -125.04 Million USD | -76.135% |
| bluebird bio, Inc. | -211.91 Million USD | -3.93% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -4304.404% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | 231.374% |
| DBV Technologies S.A. | -72.72 Million USD | -202.838% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -4304.404% |
| Moderna, Inc. | -4.71 Billion USD | 95.328% |
| Vincerx Pharma, Inc. | -40.15 Million USD | -448.453% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | -3767.968% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | -264.712% |
| Travere Therapeutics, Inc. | -111.39 Million USD | -97.706% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | -62.718% |
| Spruce Biosciences, Inc. | -47.91 Million USD | -359.613% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | -55.726% |
| Cogent Biosciences, Inc. | -192.41 Million USD | -14.465% |
| MacroGenics, Inc. | -9.05 Million USD | -2331.465% |
| RenovoRx, Inc. | -10.23 Million USD | -2052.483% |
| Adicet Bio, Inc. | -142.65 Million USD | -54.385% |
| Prime Medicine, Inc. | -198.13 Million USD | -11.159% |
| Aditxt, Inc. | -32.38 Million USD | -580.162% |
| Adagene Inc. | -18.94 Million USD | -1062.45% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -2912.178% |
| Quantum-Si incorporated | -95.96 Million USD | -129.514% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | -85.032% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -1410.808% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | 266.434% |
| SciSparc Ltd. | -5.12 Million USD | -4199.924% |
| Vericel Corporation | -3.18 Million USD | -6821.499% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -183047.425% |
| Minerva Neurosciences, Inc. | -30 Million USD | -634.009% |
| Generation Bio Co. | -126.61 Million USD | -73.95% |
| Astria Therapeutics, Inc. | -72.89 Million USD | -202.153% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | -167.148% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | 15.983% |
| Invivyd, Inc. | -198.64 Million USD | -10.873% |
| Relay Therapeutics, Inc. | -341.97 Million USD | 35.597% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | -2435.431% |
| Spero Therapeutics, Inc. | 22.8 Million USD | 1065.72% |
| Artelo Biosciences, Inc. | -9.87 Million USD | -2130.526% |
| 2seventy bio, Inc. | -217.57 Million USD | -1.228% |
| Clene Inc. | -49.5 Million USD | -344.898% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | -888.185% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | -345.528% |
| GeoVax Labs, Inc. | -25.96 Million USD | -748.169% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | 32.867% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | -576.774% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | 1069.375% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | -122.936% |
| Finch Therapeutics Group, Inc. | -74.75 Million USD | -194.623% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | -36.962% |
| Vir Biotechnology, Inc. | -615.06 Million USD | 64.192% |
| Evaxion Biotech A/S | -22.12 Million USD | -895.445% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | -172.793% |
| Verve Therapeutics, Inc. | -200.06 Million USD | -10.084% |
| Trevena, Inc. | -40.28 Million USD | -446.656% |
| Surrozen, Inc. | -43.04 Million USD | -411.691% |
| Tyra Biosciences, Inc. | -69.13 Million USD | -218.573% |
| Cingulate Inc. | -23.53 Million USD | -835.809% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | -3086.373% |
| Unity Biotechnology, Inc. | -39.86 Million USD | -452.539% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | -2756.328% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | -144.144% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | -259.368% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | -270.136% |
| Clearmind Medicine Inc. | -11.95 Million USD | -1742.255% |
| Kronos Bio, Inc. | -112.67 Million USD | -95.47% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | -218.283% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -8683738.019% |
| Viking Therapeutics, Inc. | -85.89 Million USD | -156.409% |
| Statera Biopharma, Inc. | -174.4 Million USD | -26.28% |
| ImmunityBio, Inc. | -583.19 Million USD | 62.235% |
| Korro Bio, Inc. | -81.17 Million USD | -171.328% |
| Kineta, Inc. | -14.09 Million USD | -1462.112% |
| BioVie Inc. | -32.12 Million USD | -585.674% |
| Codexis, Inc. | -76.24 Million USD | -188.88% |
| Celularity Inc. | -196.29 Million USD | -12.2% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | -2.663% |
| Celcuity Inc. | -63.77 Million USD | -245.32% |
| Virax Biolabs Group Limited | -6.73 Million USD | -3170.823% |
| Cibus, Inc. | -267.62 Million USD | 17.706% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | -446.154% |
| IN8bio, Inc. | -30 Million USD | -633.969% |
| Kodiak Sciences Inc. | -260.49 Million USD | 15.451% |
| Annexon, Inc. | -134.23 Million USD | -64.07% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | -87.976% |
| Assembly Biosciences, Inc. | -61.22 Million USD | -259.708% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | -598.206% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | 39.872% |
| Eyenovia, Inc. | -27.26 Million USD | -707.899% |
| Puma Biotechnology, Inc. | 21.59 Million USD | 1120.064% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -41066.749% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | -188.26% |
| Arcellx, Inc. | -70.69 Million USD | -211.56% |
| Cardiff Oncology, Inc. | -41.44 Million USD | -431.459% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | -64.586% |
| Regulus Therapeutics Inc. | -30.03 Million USD | -633.236% |
| Moolec Science SA | -51.78 Million USD | -325.269% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | -320.542% |
| LAVA Therapeutics N.V. | -41.97 Million USD | -424.711% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | -61.995% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | -2376.912% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | -936.764% |
| Humacyte, Inc. | -110.77 Million USD | -98.818% |
| 89bio, Inc. | -142.18 Million USD | -54.894% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | -219.377% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | -2022.406% |
| Genelux Corporation | -28.29 Million USD | -678.323% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | -657.757% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | -24.347% |
| Notable Labs, Ltd. | -11.26 Million USD | -1855.274% |
| Liquidia Corporation | -78.5 Million USD | -180.556% |
| Mustang Bio, Inc. | -51.6 Million USD | -326.809% |
| Immunovant, Inc. | -259.33 Million USD | 15.075% |
| Quantum-Si incorporated | -95.96 Million USD | -129.514% |
| Arbutus Biopharma Corporation | -72.84 Million USD | -202.327% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | -1036.382% |
| Vera Therapeutics, Inc. | -95.99 Million USD | -129.443% |
| Acasti Pharma Inc. | -12.85 Million USD | -1613.546% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | -880.691% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -1279.82% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | -20.751% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | -5020.103% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | -1666.176% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | -646.811% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | -464.897% |
| PepGen Inc. | -78.62 Million USD | -180.114% |
| Moleculin Biotech, Inc. | -29.76 Million USD | -639.837% |
| United Therapeutics Corporation | 984.8 Million USD | 122.364% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | -889.407% |
| Solid Biosciences Inc. | -96.01 Million USD | -129.383% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -4496.549% |
| Immuneering Corporation | -53.47 Million USD | -311.886% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -4229.484% |
| Silo Pharma, Inc. | -3.7 Million USD | -5851.391% |
| Belite Bio, Inc | -31.63 Million USD | -596.264% |
| XOMA Corporation | -40.83 Million USD | -439.399% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | -305.117% |
| Bionomics Limited | -15.49 Billion USD | 98.578% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -162.24% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -655.366% |
| uniQure N.V. | -308.47 Million USD | 28.604% |
| Cassava Sciences, Inc. | -97.21 Million USD | -126.547% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -2912.178% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | -78.435% |
| Forte Biosciences, Inc. | -31.47 Million USD | -599.714% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | -2585.322% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | -657.679% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -41066.749% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -739.593% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | -1236.015% |
| Altimmune, Inc. | -88.44 Million USD | -149.01% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | -45.294% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -655.366% |
| Compugen Ltd. | -18.75 Million USD | -1074.374% |
| Peak Bio, Inc. | -1259.26 USD | -17489703.932% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | -378.278% |
| Benitec Biopharma Inc. | -21.75 Million USD | -912.561% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | 34.992% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | -165.499% |
| Zura Bio Limited | -60.36 Million USD | -264.881% |
| PolyPid Ltd. | -23.86 Million USD | -822.867% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | -1299.963% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | -165.499% |
| Instil Bio, Inc. | -156.08 Million USD | -41.102% |
| argenx SE | -295.05 Million USD | 25.355% |
| Immunome, Inc. | -106.8 Million USD | -106.208% |
| Verona Pharma plc | -54.36 Million USD | -305.088% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | -120.425% |
| Shattuck Labs, Inc. | -87.29 Million USD | -152.288% |
| CervoMed Inc. | -2.17 Million USD | -10040.653% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | -76.687% |
| Plus Therapeutics, Inc. | -13.31 Million USD | -1553.966% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | -405.664% |
| Moolec Science SA | -51.78 Million USD | -325.269% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | -1273584.617% |
| Design Therapeutics, Inc. | -66.86 Million USD | -229.398% |
| Leap Therapeutics, Inc. | -81.41 Million USD | -170.521% |
| NeurAxis, Inc. | -14.62 Million USD | -1405.756% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | -481.39% |
| Lumos Pharma, Inc. | -34.03 Million USD | -547.124% |
| Achilles Therapeutics plc | -69.66 Million USD | -216.145% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | -120.425% |
| 180 Life Sciences Corp. | -19.93 Million USD | -1004.795% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | 7419.956% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -8683738.019% |
| Nutriband Inc. | -5.48 Million USD | -3915.123% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | -118.718% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | -353.108% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | -185.691% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | -548.343% |
| MoonLake Immunotherapeutics | -36 Million USD | -511.66% |
| Palisade Bio, Inc. | -12.3 Million USD | -1690.586% |
| Tourmaline Bio, Inc. | -42.12 Million USD | -422.842% |
| Beam Therapeutics Inc. | -132.52 Million USD | -66.187% |
| Neurogene Inc. | -36.31 Million USD | -506.444% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | -34.775% |
| AEON Biopharma, Inc. | -52.55 Million USD | -319.062% |
| Sesen Bio, Inc. | -19.88 Million USD | -1007.635% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | -207.669% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | -1659.98% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | 50.4% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | -97.41% |
| Athira Pharma, Inc. | -117.67 Million USD | -87.166% |
| Vaccinex, Inc. | -20.25 Million USD | -987.562% |
| HCW Biologics Inc. | -24.99 Million USD | -781.17% |
| XOMA Corporation | -40.83 Million USD | -439.399% |
| Nektar Therapeutics | -276.05 Million USD | 20.218% |
| Arvinas, Inc. | -367.3 Million USD | 40.038% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -327032.722% |
| Merus N.V. | -154.93 Million USD | -42.148% |
| Omega Therapeutics, Inc. | -97.42 Million USD | -126.056% |
| Quince Therapeutics, Inc. | -31.38 Million USD | -601.743% |
| Rezolute, Inc. | -68.45 Million USD | -221.714% |
| Clene Inc. | -49.5 Million USD | -344.898% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -1327.967% |
| BeyondSpring Inc. | -21.02 Million USD | -947.475% |
| Synlogic, Inc. | -57.28 Million USD | -284.487% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | -1750.618% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -1934.381% |
| Peak Bio, Inc. | -1259.26 USD | -17489703.932% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | -489.387% |
| Krystal Biotech, Inc. | 10.93 Million USD | 2114.655% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | -53.909% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | 32.255% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | -4668.213% |
| MannKind Corporation | -11.93 Million USD | -1744.883% |
| Ikena Oncology, Inc. | -68.16 Million USD | -223.097% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | -948.023% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | -136.99% |
| Gossamer Bio, Inc. | -179.81 Million USD | -22.481% |
| CohBar, Inc. | -11.96 Million USD | -1741.163% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | -754.049% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -630.488% |
| Legend Biotech Corporation | -518.25 Million USD | 57.503% |
| Mural Oncology plc | -207.44 Million USD | -6.168% |
| Biora Therapeutics, Inc. | -124.11 Million USD | -77.45% |
| PaxMedica, Inc. Common Stock | -18.28 Million USD | -1104.185% |
| Disc Medicine, Inc. | -76.42 Million USD | -188.166% |
| Champions Oncology, Inc. | -7.27 Million USD | -2926.967% |
| REGENXBIO Inc. | -263.49 Million USD | 16.415% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | -1975.196% |
| Anavex Life Sciences Corp. | -47.5 Million USD | -363.619% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | -479.836% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | -119.884% |
| Vaxart, Inc. | -82.46 Million USD | -167.073% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | 66087.574% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | -486.647% |
| Cellectis S.A. | -101.05 Million USD | -117.934% |
| Longeveron Inc. | -21.41 Million USD | -928.544% |
| Repare Therapeutics Inc. | -93.79 Million USD | -134.81% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | 58.908% |
| Inozyme Pharma, Inc. | -71.16 Million USD | -209.464% |
| Revolution Medicines, Inc. | -436.36 Million USD | 49.528% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | -3251.729% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | -614.515% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | -217.658% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | -240.237% |
| Anixa Biosciences, Inc. | -9.81 Million USD | -2144.849% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | 106.085% |
| Denali Therapeutics Inc. | -145.22 Million USD | -51.657% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -183047.425% |
| Veru Inc. | -93.15 Million USD | -136.431% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | -714.836% |
| Cingulate Inc. | -23.53 Million USD | -835.809% |
| Passage Bio, Inc. | -102.06 Million USD | -115.792% |
| Context Therapeutics Inc. | -23.96 Million USD | -819.046% |
| Exicure, Inc. | -16.91 Million USD | -1202.129% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | -16.581% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | -483.207% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | -3284.526% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | -19.257% |
| Nuvalent, Inc. | -126.21 Million USD | -74.492% |
| ABVC BioPharma, Inc. | -10.51 Million USD | -1994.421% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | -153.504% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | -621.065% |
| OmniAb, Inc. | -50.61 Million USD | -335.098% |
| Anew Medical, Inc. | 1.34 Million USD | 16461.193% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | -1272.653% |
| Lipocine Inc. | -16.35 Million USD | -1246.875% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | -231.72% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | -245.885% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -421.978% |
| G1 Therapeutics, Inc. | -47.96 Million USD | -359.153% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | -1010.595% |
| Sage Therapeutics, Inc. | -541.48 Million USD | 59.327% |
| Ocugen, Inc. | -63.07 Million USD | -249.158% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | -130.061% |
| Q32 Bio Inc. | -112.96 Million USD | -94.972% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | -1181.073% |
| Alumis Inc. Common Stock | -154.99 Million USD | -42.098% |
| Equillium, Inc. | -13.33 Million USD | -1551.609% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | -264.845% |
| Coya Therapeutics, Inc. | -7.98 Million USD | -2657.219% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | -1068.317% |
| Galera Therapeutics, Inc. | -59.08 Million USD | -272.774% |
| Evelo Biosciences, Inc. | -114.52 Million USD | -92.306% |
| Comera Life Sciences Holdings, Inc. | -18.37 Million USD | -1098.404% |
| Dominari Holdings Inc. | -22.88 Million USD | -862.512% |
| Edesa Biotech, Inc. | -8.37 Million USD | -2529.94% |
| vTv Therapeutics Inc. | -20.25 Million USD | -987.615% |
| Bio-Techne Corporation | 168.1 Million USD | 231.015% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | 37.447% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | 270.925% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | -80.775% |
| Candel Therapeutics, Inc. | -37.93 Million USD | -480.516% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | -95.524% |
| Nkarta, Inc. | -117.5 Million USD | -87.438% |
| BioCardia, Inc. | -11.57 Million USD | -1803.397% |
| Iterum Therapeutics plc | -38.37 Million USD | -473.981% |